Development of a T Cell-Based COVID-19 Vaccine Using a Live Attenuated Influenza Vaccine Viral Vector.
Isakova-Sivak I, Stepanova E, Matyushenko V, Niskanen S, Mezhenskaya D, Bazhenova E, Krutikova E, Kotomina T, Prokopenko P, Neterebskii B, Doronin A, Vinogradova E, Yakovlev K, Sivak K, Rudenko L.
Isakova-Sivak I, et al.
Vaccines (Basel). 2022 Jul 18;10(7):1142. doi: 10.3390/vaccines10071142.
Vaccines (Basel). 2022.
PMID: 35891306
Free PMC article.